Chemotherapy with gemcitabine, cisplatin, and docetaxel in the treatment for patients with muscle-invasive bladder cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)-Reference-Cited by-同舟云学术

Chemotherapy with gemcitabine, cisplatin, and docetaxel in the treatment for patients with muscle-invasive bladder cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)

Published:2011-07-12 Issue:2 Volume:69 Page:351-356
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Boukovinas Ioannis,Androulakis Nikolaos,Kentepozidis Nikolaos,Polyzos Aris,Papakotoulas Pavlos,Ziras Nikolaos,Kotsakis Athanasios,Vardakis Nikolaos,Karampeazis Athanasios,Markos Vassilis,Kostakopoulos Athanasios,Constantinides Constantine A.,Samonis George,Mavroudis Dimitris,Georgoulias Vassilis

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-011-1694-9.pdf

Reference25 articles.

1. National Comprehensive Cancer Network (2008) Clinical practice guidelines in oncology: non-small cell lung cancer v.2.2008

2. Bellmunt J, Albiol S, Kataja V (2009) Invasive bladder cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 20(Suppl 4):79–80

3. von der Maase MH, Hansen SW, Roberts JT, Dogliotti L, Oliver T, Moore MJ, Bodrogi I, Albers P, Knuth A, Lippert CM, Kerbrat P, Sanchez RP, Wersall P, Cleall SP, Roychowdhury DF, Tomlin I, Visseren-Grul CM, Conte PF (2000) Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol 18:3068–3077

4. von der Maase H, Sengelov L, Roberts JT, Ricci S, Dogliotti L, Oliver T, Moore MJ, Zimmermann A, Arning M (2005) Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer. J Clin Oncol 23:4602–4608

5. Sternberg CN, Yagoda A, Scher HI, Watson RC, Geller N, Herr HW, Morse MJ, Sogani PC, Vaughan ED, Bander N (1989) Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse. Cancer 64:2448–2458

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Chemotherapy in Locally Advanced and Metastatic Bladder Cancer;Management of Urology;2021

2. The Impact of Adding Taxanes to Gemcitabine and Platinum Chemotherapy for the First-Line Therapy of Advanced or Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis;European Urology;2016-04

3. The safety and efficacy of gemcitabine for the treatment of bladder cancer;Expert Review of Anticancer Therapy;2016-02-09

4. Does radical cystectomy outperform other bladder preservative treatments in elderly patients with advanced bladder cancer?;Journal of the Chinese Medical Association;2015-08

5. Harnblasenkarzinom;Uroonkologie;2014